The goal of this program is to provide important clinical data on issues related to the management of HCV.
This activity has been designed to meet the educational needs of hepatologists, gastroenterologists, physician assistants, and nurse practitioners involved in the care of patients with HCV.
Upon completion of this activity, the participants should be better able to:
Describe the detrimental effects of chronic hepatitis C virus (HCV) to emphasize the need for diagnosis, treatment, and long-term patient management
Demonstrate strategies for incorporating treatment updates into clinical practice to optimize initial treatment and ongoing care for patients with HCV
Analyze recently approved and emerging treatment options in order to recognize how new agents improve the standard of care for all patients chronically infected with HCV
Identify the patient characteristics that are important to consider when selecting the most appropriate treatment regimen for maximizing HCV patient outcomes
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and the Chronic Liver Disease Foundation (CLDF). The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.
The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™.
Physicians should only claim credit commensurate with the extent of their participation in the activity.
The Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
A maximum of 1.5 contact hours may be earned for successful completion of this activity.
Disclosure of Conflicts of Interest
All faculty and staff involved in the planning or presentation of continuing education activities sponsored/provided by the Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. John Bayliss, VP, Business Development, spouse is an employee of Amgen, Inc.; all other staff at the Annenberg Center for Health Sciences at Eisenhower and the Chronic Liver Disease Foundation (CLDF) have no relationships to disclose.
The opinions expressed during the live activity are those of the faculty and do not necessarily represent the views of the Annenberg Center for Health Sciences at Eisenhower. The information is presented for the purpose of advancing the attendees’ professional development.
Learner Assurance Statement
The Annenberg Center for Health Sciences at Eisenhower is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members’ significant relationships with drug or device manufacturer(s). The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.
Americans with Disabilities Act
The event staff will be glad to assist you with any special requirements (i.e. physical, dietary, etc.). Please contact us prior to the event at 888-565-5321.
For additional educational information or to register online, please visit chronicliverdisease.org.
If you no longer wish to receive faxes from CLDF, please send a request via email to firstname.lastname@example.org, via fax to 888-862-9650, or call 888-582-4532.
This program is supported by educational grants from AbbVie and Bristol-Myers Squibb.